KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Accounts Payables (2016 - 2025)

LifeMD's Accounts Payables history spans 14 years, with the latest figure at $14.1 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 29.75% year-over-year to $14.1 million; the TTM value through Dec 2025 reached $14.1 million, up 29.75%, while the annual FY2025 figure was $14.1 million, 29.75% up from the prior year.
  • Accounts Payables reached $14.1 million in Q4 2025 per LFMD's latest filing, down from $19.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $24.3 million in Q2 2025 to a low of $6.9 million in Q1 2023.
  • Average Accounts Payables over 5 years is $13.4 million, with a median of $12.2 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: soared 188.92% in 2021, then crashed 41.25% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $9.1 million in 2021, then grew by 11.56% to $10.1 million in 2022, then rose by 9.68% to $11.1 million in 2023, then decreased by 1.63% to $10.9 million in 2024, then rose by 29.75% to $14.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Accounts Payables are $14.1 million (Q4 2025), $19.6 million (Q3 2025), and $24.3 million (Q2 2025).